ACCESS Newswire

OXCCU

Share
Creating Jet Fuel From Thin Air: OXCCU Secures Share of UK Government Investment to Transform Carbon Dioxide Into Sustainable Aviation Fuel

Pioneering research developed over a decade at the University of Oxford, OXCCU has been awarded grant through the UK government's Advanced Fuels Fund

OXFORD, ENGLAND / ACCESSWIRE / November 20, 2023 / OXCCU, a leading carbon-to-value company converting carbon dioxide and hydrogen into industrial and consumer products, has won a £2.8 million grant along with the University of Sheffield Translational Energy Research Centre (TERC) and Coryton. The capital will be used to demonstrate the world's first direct carbon dioxide (CO2) hydrogenation process, turning CO2 directly into aviation fuel range hydrocarbons, also known as sustainable aviation fuel (SAF).

The project presents a novel approach to SAF production, directly converting CO2 and hydrogen (H2) to hydrocarbons - essentially creating jet fuel from thin air. OXCCU technology means that this traditionally multi-step process has been simplified to just a single step. A truly British innovation, the reactor will be located at the TERC and fed with biogenic CO2 captured from biomass combustion and H2 produced on site from electrolysis using green electricity. The fuel is then blended via Coryton to produce a fuel of Jet A-1 specification.

As part of its aim to cement the UK's status as a world leader in SAF, last month the UK Government announced new measures to support the industry, with a revenue certainty scheme to boost uptake and help create jobs. The Government has committed to having at least five commercial SAF plants under construction in the UK by 2025, viewing low or zero emission technologies as key to sustainability and net zero targets.

Aviation still needs hydrocarbons but to achieve net zero, they need to be created without the use of fossil fuels. Traditional biofuels have well-known issues with scale due to limited feedstocks. In contrast, e-fuels or synthetic fuels based on CO2 have enormous potential to scale with fewer feedstock constraints but face challenges due to cost. OXCCU's patented technology consolidates the traditional e-hydrocarbons production process from two-steps, Reverse Water Gas Shift (RWGS) then Fischer-Tropsch, to a one-step direct hydrogenation process. This offers a radically cost-effective solution and opens up intriguing opportunities for the future of commercial aviation.

OXCCU CEO Andrew Symes said: "We're proud to be part of the UK's journey to cement itself as a leader in clean aviation and to help scale world-first technologies in sustainable aviation fuel. This new investment from the AFF will be a welcome contribution to our efforts to help the industry meet the high targets it has set."

Available to customers as OXEFUEL, OXCCU's sustainable aviation fuel is created by combining captured carbon dioxide and renewably-sourced green hydrogen through a novel iron-based catalyst, resulting in a more cost-effective and decarbonized alternative to fossil-based Jet A fuel for commercial airlines. Modelling completed by independent researchers from Imperial College London, through Imperial Consultants, has shown OXCCU's one-step process significantly reduces SAF cost due to higher selectivity yield in the jet fuel range and a 50% lower capital cost.

-Ends-

About OXCCU TECH LTD

OXCCU, a climate tech spin-out company from the University of Oxford, is developing novel catalysts and reactor designs to convert carbon dioxide and hydrogen into hydrocarbons with high conversion and selectivity for use as fuels, chemicals and plastics. The company is headquartered in the UK, with operations at Begbroke Science Park, Oxford, and London Oxford Airport.

Contact Information

Gemma Dodd
gem@shift6studios.com
+44 7585 126262

Melissa Tirey
melissa@shift6studios.com
+1 646 823 6776

SOURCE: OXCCU

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/802752/creating-jet-fuel-from-thin-air-oxccu-secures-share-of-uk-government-investment-to-transform-carbon-dioxide-into-sustainable-aviation-fuel

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Karbon-X Advances Community-Led Forest Protection in Colombia's Meta Region19.11.2025 15:00:00 CET | Press release

New phase of the Sur del Meta Project expands carbon and biodiversity monitoring while strengthening local governance and livelihoods. CALGARY, AB / ACCESS Newswire / November 19, 2025 / In the heart of Colombia's Meta department, where forests and farmlands converge, Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company") is deepening its commitment to people-powered climate solutions through the REDD+ Sur del Meta Project - a long-term conservation initiative that protects 40,637 hectares of natural forest while supporting sustainable livelihoods for nearly 1,000 local families. Developed through ALLCOT - A Karbon-X Company, the project development and advisory arm of Karbon-X, the initiative operates across the municipalities of Vistahermosa, Puerto Rico, Puerto Concordia, and Puerto Lleras, a region historically affected by deforestation and armed conflict. The project partners with local farmers, many of whom are victims of Colombia's armed conflict, helping them transition from

eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release

MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye

IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release

Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres

General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release

DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye